Back to Search Start Over

Supplementary Figure 2 from Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors

Authors :
Johanna C. Bendell
Eric Laille
Kejian Liu
Aaron Nguyen
Jorge DiMartino
Gordon L. Bray
Patricia M. LoRusso
Miguel Martin
W. Jeff Edenfield
Jose A. Lopez-Martin
Ron H.J. Mathijssen
Bert O'Neil
Christophe Le Tourneau
Nicolas Isambert
Jan H.M. Schellens
Pamela N. Munster
Elisabeth I. Heath
Drew W. Rasco
Daniel D. Von Hoff
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Mean paclitaxel plasma concentrations following nab-paclitaxel administration alone or with CC-486 in part 1 arm B

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....4eefdbd5b10a450837b99a92154c80bc
Full Text :
https://doi.org/10.1158/1078-0432.22469373